SCHEMBL18663329

SCHEMBL18663329

CCC1=C(c2ccc(Cl)cc2)C(C(=O)O)(C(=O)O)c2ccccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ SLC6A4 P31645 1/20 0.38
▸ SLC6A3 Q01959 1/20 0.38
▸ MDM2 Q00987 2/20 0.37
▸ HSP90AA1 P07900 3/20 0.35
▸ HSP90AB1 P08238 2/20 0.35
▸ PGR P06401 2/20 0.35
▸ THRB P10828 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ PDK2 Q15119 1/20 0.35
▸ KDM4E B2RXH2 3/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ HPGD P15428 2/20 0.34
▸ GABRA2 P47869 1/20 0.34
▸ GABRB2 P47870 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ LMNA P02545 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18663412 0.82 PDK2 (0.34) THRBPDK2GABRA2GABRB2PTGS2
SCHEMBL18663400 0.72 PDK2 (0.40) CYP1A2CYP2C19THRBTDP1PDK2
SCHEMBL18663304 0.66 THRB (0.64) HSP90AA1HSP90AB1THRBTDP1PDK2
SCHEMBL18663305 0.66 OPRK1 (0.37) THRBTDP1KDM4EALDH1A1HPGD
SCHEMBL19690707 0.65 ALDH1A1 (0.41) CYP1A2CYP2C19HSP90AA1TDP1KDM4E
SCHEMBL10058354 0.64 PTGS2 (0.52) CYP1A2CYP2C19SLC6A4SLC6A3KDM4E
SCHEMBL18663308 0.62 TDP1 (0.38) HSP90AA1HSP90AB1THRBTDP1PDK2
SCHEMBL18663408 0.62 THRB (0.41) THRBTDP1PDK2
SCHEMBL7536487 0.61 SLC6A4 (0.61) CYP2C19SLC6A4SLC6A3TDP1PDK2
SCHEMBL23658935 0.60 PTGS2 (0.52) CYP1A2SLC6A4SLC6A3HSP90AA1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170088642-A1 CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST CONTAINING CATALYST COMPONENT AND USE THEREOF BEIJING LIHE TECH LTD (CN) 2017-03-30 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088642-A1 CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST CONTAINING CATALYST COMPONENT AND USE THEREOF TEC, DGAT2, MOGAT2 CYP1A2 1003/4885CYP2C19 631/4885HIF1A 3785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback